{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:24:52Z","timestamp":1787181892124,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.biopha.2026.119797","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T13:34:21Z","timestamp":1785936861000},"page":"119797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Paclitaxel-loaded nanostructured lipid carriers surface-functionalized with N6L for pancreatic cancer"],"prefix":"10.1016","volume":"202","author":[{"given":"Laura","family":"Larue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Brissault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9a","family":"Chesneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Houppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Michely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cascone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Belbekhouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2026.119797_bib1","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA A Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.biopha.2026.119797_bib2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.3390\/cancers16081589","article-title":"Targeted nanoparticle-based diagnostic and treatment options for pancreatic cancer","volume":"16","author":"Gu","year":"2024","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.biopha.2026.119797_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.biopha.2026.119797_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","article-title":"Therapeutic Developments in Pancreatic Cancer: Current and Future Perspectives","volume":"15","author":"Neoptolemos","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119797_bib5","article-title":"Unraveling Pancreatic Cancer: Epidemiology, Risk Factors, and Global Trends","volume":"16","author":"Qadir","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2026.119797_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1521788","article-title":"Global, Regional and National Burden of Pancreatic Cancer and Its Attributable Risk Factors from 2019 to 2021, with Projection to 2044","volume":"14","author":"Li","year":"2025","journal-title":"Front. Oncol."},{"issue":"17","key":"10.1016\/j.biopha.2026.119797_bib7","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.3390\/cancers14174257","article-title":"Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies","volume":"14","author":"Bazeed","year":"2022","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.biopha.2026.119797_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16223863","article-title":"Altered mechanobiology of PDAC cells with acquired chemoresistance to gemcitabine and paclitaxel","volume":"16","author":"Gregori","year":"2024","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.biopha.2026.119797_bib9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s11051-017-4042-0","article-title":"Lipid-based nanoparticles as drug delivery system for paclitaxel in breast cancer treatment","volume":"19","author":"de Sousa Marcial","year":"2017","journal-title":"J. Nanopart. Res."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2026.119797_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(98)00188-4","article-title":"Pharmaceutical aspects of paclitaxel","volume":"172","author":"Panchagnula","year":"1998","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1476-511X-11-159","article-title":"Nanostructured Lipid Carriers: A Potential Drug Carrier for Cancer Chemotherapy","volume":"11","author":"Selvamuthukumar","year":"2012","journal-title":"Lipids Health Dis."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2026.119797_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured Lipid Matrices for Improved Microencapsulation of Drugs","volume":"242","author":"M\u00fcller","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2026.119797_bib13","first-page":"243","article-title":"Nanostructured Lipid Carriers as a Drug Delivery System: A Comprehensive Review with Therapeutic Applications","volume":"3","author":"Mall","year":"2025","journal-title":"Intell. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2026.119797_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15061593","article-title":"Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review","volume":"15","author":"Viegas","year":"2023","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.biopha.2026.119797_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40005-017-0329-5","article-title":"Surface Modification of Lipid-Based Nanocarriers for Cancer Cell-Specific Drug Targeting","volume":"47","author":"Kim","year":"2017","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.biopha.2026.119797_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125736","article-title":"Nanostructured Lipid Carriers in Cancer Therapy: Advances in Passive and Active Targeting Strategies","volume":"678","author":"Alkhamach","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119797_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2014.05.004","article-title":"Targeted Anticancer Therapy: Overexpressed Receptors and Nanotechnology","volume":"436","author":"Akhtar","year":"2014","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/acsomega.2c05976","article-title":"Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery","volume":"8","author":"Priya","year":"2023","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.biopha.2026.119797_bib19","article-title":"Advancement in Design of Nanostructured Lipid Carriers for Cancer Targeting and Theranostic Application","volume":"1865","author":"Md","year":"2021","journal-title":"Biochim. Et. Biophys. Acta (BBA) - General. Subj."},{"issue":"3","key":"10.1016\/j.biopha.2026.119797_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/21691401.2013.801848","article-title":"Small Peptide-Modified Nanostructured Lipid Carriers Distribution and Targeting to EGFR-Overexpressing Tumor in Vivo","volume":"42","author":"Han","year":"2014","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.biopha.2026.119797_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2025.112900","article-title":"An Oral Delivery Approach for Riboflavin-Targeted Platinum(II)-Loaded Lipid Nanoparticles into Alginate-Gelatin Matrices against 2D and 3D Colorectal Carcinoma Models","volume":"269","author":"Boztepe","year":"2025","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biopha.2026.119797_bib22","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.2147\/IJN.S83211","article-title":"Engineering of Lipid Prodrug-Based, Hyaluronic Acid-Decorated Nanostructured Lipid Carriers Platform for 5-Fluorouracil and Cisplatin Combination Gastric Cancer Therapy","author":"Lei-Ming","year":"2015","journal-title":"IJN"},{"issue":"2","key":"10.1016\/j.biopha.2026.119797_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.canlet.2012.07.002","article-title":"Hyaluronic Acid-Coated Nanostructured Lipid Carriers for Targeting Paclitaxel to Cancer","volume":"334","author":"Yang","year":"2013","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.biopha.2026.119797_bib24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00280-020-04048-6","article-title":"Docetaxel-Loaded Ultrasmall Nanostructured Lipid Carriers for Cancer Therapy: In Vitro and in Vivo Evaluation","volume":"85","author":"Li","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119797_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejpb.2022.09.009","article-title":"Chitosan-Functionalized Nanostructured Lipid Carriers Containing Chloroaluminum Phthalocyanine for Photodynamic Therapy of Skin Cancer","volume":"179","author":"Almeida","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2026.119797_bib26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/IJN.S77837","article-title":"Targeted Lung Cancer Therapy: Preparation and Optimization of Transferrin-Decorated Nanostructured Lipid Carriers as Novel Nanomedicine for Co-Delivery of Anticancer Drugs and DNA","author":"Shao","year":"2015","journal-title":"IJN"},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12951-022-01764-4","article-title":"Phosphorothioated Amino-AS1411 Aptamer Functionalized Stealth Nanoliposome Accelerates Bio-Therapeutic Threshold of Apigenin in Neoplastic Rat Liver: A Mechanistic Approach","volume":"21","author":"Dhara","year":"2023","journal-title":"J. Nanobiotechnol"},{"key":"10.1016\/j.biopha.2026.119797_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2024.213924","article-title":"Alendronate\/Lactoferrin-Dual Decorated Lipid Nanocarriers for Bone-Homing and Active Targeting of Ivermectin and Methyl Dihydrojasmonate for Leukemia","volume":"162","author":"Abou-Elnour","year":"2024","journal-title":"Biomater. Adv."},{"issue":"6","key":"10.1016\/j.biopha.2026.119797_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002518","article-title":"Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin","volume":"3","author":"Destouches","year":"2008","journal-title":"PLOS ONE"},{"key":"10.1016\/j.biopha.2026.119797_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biochi.2015.03.023","article-title":"The Roles of Nucleolin Subcellular Localization in Cancer","volume":"113","author":"Berger","year":"2015","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.biopha.2026.119797_bib31","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1158\/0008-5472.CAN-10-3459","article-title":"A Simple Approach to Cancer Therapy Afforded by Multivalent Pseudopeptides That Target Cell-Surface Nucleoproteins","volume":"71","author":"Destouches","year":"2011","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119797_bib32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3892\/ijmm.2023.5284","article-title":"Nucleolin\u2011based Targeting Strategies in Cancer Treatment: Focus on Cancer Immunotherapy (Review)","volume":"52","author":"Thongchot","year":"2023","journal-title":"Int. J. Mol. Med."},{"issue":"52","key":"10.1016\/j.biopha.2026.119797_bib33","doi-asserted-by":"crossref","first-page":"90108","DOI":"10.18632\/oncotarget.21441","article-title":"Multivalent Cationic Pseudopeptide Polyplexes as a Tool for Cancer Therapy","volume":"8","author":"Diamantopoulou","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119797_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2020.125461","article-title":"N6L-Functionalized Nanoparticles for Targeted and Inhibited Pancreatic Cancer Cells","volume":"607","author":"Belbekhouche","year":"2020","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.biopha.2026.119797_bib35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.canlet.2017.10.038","article-title":"N6L Pseudopeptide Interferes with Nucleophosmin Protein-Protein Interactions and Sensitizes Leukemic Cells to Chemotherapy","volume":"412","author":"De Cola","year":"2018","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.biopha.2026.119797_bib36","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.3390\/cancers13122986","article-title":"Nucleolin Targeting by N6L Inhibits Wnt\/\u03b2-Catenin Pathway Activation in Pancreatic Ductal Adenocarcinoma","volume":"13","author":"Raineri","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2026.119797_bib37","article-title":"I. The Nucleolin Antagonist N6L and Paclitaxel Combination Treatment Could Be a New Promising Therapeutic Strategy for Pancreatic Ductal Adenocarcinoma Therapy","volume":"991","author":"Raineri","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119797_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/nano7060122","article-title":"A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs","volume":"7","author":"Li","year":"2017","journal-title":"Nanomaterials"},{"issue":"3","key":"10.1016\/j.biopha.2026.119797_bib39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11095-008-9763-4","article-title":"Design of Biodegradable Nanoparticles for Oral Delivery of Doxorubicin: In Vivo Pharmacokinetics and Toxicity Studies in Rats","volume":"26","author":"Kalaria","year":"2009","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/358782","article-title":"Formulation of LDL Targeted Nanostructured Lipid Carriers Loaded with Paclitaxel: A Detailed Study of Preparation, Freeze Drying Condition, and In Vitro Cytotoxicity","volume":"2012","author":"Emami","year":"2012","journal-title":"J. Nanomater."},{"issue":"12","key":"10.1016\/j.biopha.2026.119797_bib41","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3390\/ma14123197","article-title":"Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses","volume":"14","author":"Cort\u00e9s","year":"2021","journal-title":"Materials"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2026.119797_bib42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2007.07.025","article-title":"Nimodipine Loaded Lipid Nanospheres Prepared by Solvent Diffusion Method in a Drug Saturated Aqueous System","volume":"348","author":"Hu","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1208\/s12249-011-9733-8","article-title":"Nanostructured Lipid Carriers (NLC) for Parenteral Delivery of an Anticancer Drug","volume":"13","author":"Chinsriwongkul","year":"2012","journal-title":"AAPS PharmSciTech"},{"issue":"1\u20132","key":"10.1016\/j.biopha.2026.119797_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2008.06.002","article-title":"Reversal Activity of Nanostructured Lipid Carriers Loading Cytotoxic Drug in Multi-Drug Resistant Cancer Cells","volume":"361","author":"Zhang","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2026.119797_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle Size on In Vivo pharmacokinetics and cellular interaction","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine"},{"issue":"9","key":"10.1016\/j.biopha.2026.119797_bib46","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic Nanoparticles and Their Targeted Delivery Applications","volume":"25","author":"Yetisgin","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2026.119797_bib47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jddst.2019.02.017","article-title":"Nanostructured Lipid Carriers (NLC) System: A Novel Drug Targeting Carrier","volume":"51","author":"Salvi","year":"2019","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2026.119797_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.colsurfb.2013.08.009","article-title":"Tamoxifen-Loaded Nanostructured Lipid Carrier as a Drug Delivery System: Characterization, Stability Assessment and Cytotoxicity","volume":"112","author":"How","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"7","key":"10.1016\/j.biopha.2026.119797_bib49","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40005-015-0224-x","article-title":"Development and Evaluation of Lipid Nanoparticles for Paclitaxel Delivery: A Comparison between Solid Lipid Nanoparticles and Nanostructured Lipid Carriers","volume":"45","author":"Xu","year":"2015","journal-title":"J. Pharm. Investig."},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib50","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1080\/10717544.2020.1754526","article-title":"Gefitinib Loaded Nanostructured Lipid Carriers: Characterization, Evaluation and Anti-Human Colon Cancer Activity in Vitro","volume":"27","author":"Makeen","year":"2020","journal-title":"Drug. Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijpharm.2011.05.008","article-title":"Lipid Nanocarriers for Dermal Delivery of Lutein: Preparation, Characterization, Stability and Performance","volume":"414","author":"Mitri","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2026.119797_bib52","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/pharmaceutics12030288","article-title":"Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review","volume":"12","author":"Haider","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2026.119797_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118705","article-title":"Development, Characterization and Pharmacokinetics of Mupirocin-Loaded Nanostructured Lipid Carriers (NLCs) for Intravascular Administration","volume":"571","author":"Alcantara","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"23","key":"10.1016\/j.biopha.2026.119797_bib54","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1016\/S0142-9612(03)00331-4","article-title":"Physico-Chemical Stability of Colloidal Lipid Particles","volume":"24","author":"Heurtault","year":"2003","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.biopha.2026.119797_bib55","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1208\/s12249-010-9553-2","article-title":"Formulation of a Novel Oxybenzone-Loaded Nanostructured Lipid Carriers (NLCs)","volume":"11","author":"Sanad","year":"2010","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.biopha.2026.119797_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11144-006-0034-2","article-title":"Catalytic Wet Air Oxidation of Oleic Acid on Ceria-Supported Platinum Catalyst.Effect of pH","volume":"87","author":"Levasseur","year":"2006","journal-title":"React. Kinet. Catal. Lett."},{"key":"10.1016\/j.biopha.2026.119797_bib57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s11671-018-2728-6","article-title":"Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles","volume":"13","author":"Foroozandeh","year":"2018","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.biopha.2026.119797_bib58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: A Review Emphasizing on Particle Structure and Drug Release","volume":"133","author":"Gordillo-Galeano","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"9","key":"10.1016\/j.biopha.2026.119797_bib59","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1745-7254.2008.00829.x","article-title":"Development and Evaluation of Lipid Nanoparticles for Camptothecin Delivery: A Comparison of Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, and Lipid Emulsion","volume":"29","author":"Huang","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/ejlt.201800347","article-title":"\u0392-sitosterol Lipid Nano Carrier Based on Propolis Wax and Pomegranate Seed Oil: Effect of Thermal Processing, pH, and Ionic Strength on Stability and Structure","volume":"121","author":"Soleimanian","year":"2019","journal-title":"Eur. J. Lipid Sci. Tech."},{"key":"10.1016\/j.biopha.2026.119797_bib61","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.foodres.2017.12.036","article-title":"Enhancing the Physicochemical Stability of \u03b2-Carotene Solid Lipid Nanoparticle (SLNP) Using Whey Protein Isolate","volume":"105","author":"Mehrad","year":"2018","journal-title":"Food Res. Int."},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12668-016-0391-x","article-title":"Development of Doxorubicin-Loaded Nanostructured Lipid Carriers: Preparation, Characterization, and In Vitro Evaluation on MCF-7 Cell Line","volume":"7","author":"Abdolahpour","year":"2017","journal-title":"BioNanoSci"},{"key":"10.1016\/j.biopha.2026.119797_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201600693","article-title":"Arginine-Modified Nanostructured Lipid Carriers with Charge-Reversal and pH-Sensitive Membranolytic Properties for Anticancer Drug Delivery","volume":"6","author":"Sun","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2026.119797_bib64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.foodchem.2013.09.095","article-title":"Effect of Aqueous pH and Electrolyte Concentration on Structure, Stability and Flow Behavior of Non-Ionic Surfactant Based Solid Lipid Nanoparticles","volume":"147","author":"Choi","year":"2014","journal-title":"Food Chem."},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acssuschemeng.6b00991","article-title":"pH Responsive Bioactive Lead Sulfide Nanomaterials: Protein Induced Morphology Control, Bioapplicability, and Bioextraction of Nanomaterials","volume":"5","author":"Mahal","year":"2017","journal-title":"ACS Sustain. Chem. Eng."},{"issue":"10","key":"10.1016\/j.biopha.2026.119797_bib66","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1007\/s13197-017-2749-7","article-title":"Stability of Astaxanthin-Loaded Nanostructured Lipid Carriers as Affected by pH, Ionic Strength, Heat Treatment, Simulated Gastric Juice and Freeze\u2013Thawing","volume":"54","author":"Tamjidi","year":"2017","journal-title":"J. Food Sci. Technol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119797_bib67","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1039\/C0NR00698J","article-title":"Electrostatics at the Nanoscale","volume":"3","author":"Walker","year":"2011","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2026.119797_bib68","unstructured":"United State Pharmacopoeia 2018 USP 41- NF 36 pdf free download. https:\/\/www.webofpharma.com\/2021\/05\/united-state-pharmacopoeia-2018-usp-41.html (accessed 2024-10-09)."},{"key":"10.1016\/j.biopha.2026.119797_bib69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jconrel.2016.06.017","article-title":"DLS and Zeta Potential \u2013 What They Are and What They Are Not?","volume":"235","author":"Bhattacharjee","year":"2016","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.biopha.2026.119797_bib70","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0939-6411(01)00167-9","article-title":"Electrolyte- and pH-Stabilities of Aqueous Solid Lipid Nanoparticle (SLN\u2122) Dispersions in Artificial Gastrointestinal Media","volume":"52","author":"Zimmermann","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.biopha.2026.119797_bib71","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-5173(98)00092-1","article-title":"Effect of Light and Temperature on Zeta Potential and Physical Stability in Solid Lipid Nanoparticle (SLN\u2122) Dispersions","volume":"168","author":"Freitas","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2026.119797_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102162","article-title":"Nanoparticle Processing: Understanding and Controlling Aggregation","volume":"279","author":"Shrestha","year":"2020","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.biopha.2026.119797_bib73","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3139\/113.110308","article-title":"Aggregation Behavior of PEO-PPO-PEO Tri-Block Copolymer (Pluronic \u00ae L64) in Nonionic Surfactant Additives Environment","volume":"51","author":"Sharma","year":"2014","journal-title":"Tenside Surfactants Deterg."},{"key":"10.1016\/j.biopha.2026.119797_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.580118","article-title":"Lipid Nanoparticles as Carriers for Bioactive Delivery","volume":"9","author":"Dhiman","year":"2021","journal-title":"Front. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2026.119797_bib75","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3390\/pharmaceutics13091330","article-title":"A Traffic Light System to Maximize Carbohydrate Cryoprotectants\u2019 Effectivity in Nanostructured Lipid Carriers\u2019 Lyophilization","volume":"13","author":"Rouco","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib76","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1208\/s12249-010-9382-3","article-title":"Freeze Thaw: A Simple Approach for Prediction of Optimal Cryoprotectant for Freeze Drying","volume":"11","author":"Date","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2026.119797_bib77","series-title":"Lipid Nanoparticles: Production, Characterization and Stability; SpringerBriefs in Pharmaceutical Science & Drug Development","author":"Shah","year":"2015"},{"issue":"1","key":"10.1016\/j.biopha.2026.119797_bib78","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10973-014-4275-4","article-title":"Effect of Cryoprotectants on the Reconstitution of Silica Nanoparticles Produced by Sol\u2013Gel Technology","volume":"120","author":"Andreani","year":"2015","journal-title":"J. Therm. Anal. Calorim."},{"issue":"4","key":"10.1016\/j.biopha.2026.119797_bib79","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.carbpol.2012.01.051","article-title":"Freeze-Drying of Nanostructure Lipid Carriers by Different Carbohydrate Polymers Used as Cryoprotectants","volume":"88","author":"Varshosaz","year":"2012","journal-title":"Carbohydr. Polym."},{"issue":"5","key":"10.1016\/j.biopha.2026.119797_bib80","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/21691401.2017.1366333","article-title":"Nanocarriers in Advanced Drug Targeting: Setting Novel Paradigm in Cancer Therapeutics","volume":"46","author":"Md. H","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"24","key":"10.1016\/j.biopha.2026.119797_bib81","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1158\/0008-5472.CAN-16-0300","article-title":"Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature","volume":"76","author":"Gilles","year":"2016","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.119797_bib82","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1021\/acsnano.8b03800","article-title":"Enhanced Transdermal Drug Delivery by Transfersome-Embedded Oligopeptide Hydrogel for Topical Chemotherapy of Melanoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.biopha.2026.119797_bib83","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.3109\/10717544.2015.1064186","article-title":"Novel RGD Containing, Temozolomide-Loading Nanostructured Lipid Carriers for Glioblastoma Multiforme Chemotherapy","volume":"23","author":"Song","year":"2016","journal-title":"Drug. Deliv."},{"issue":"8","key":"10.1016\/j.biopha.2026.119797_bib84","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1158\/0008-5472.CAN-11-3883","article-title":"OA02\u201d Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo","volume":"72","author":"Xiao","year":"2012","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2026.119797_bib85","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijpharm.2014.05.032","article-title":"Free Paclitaxel Loaded PEGylated-Paclitaxel Nanoparticles: Preparation and Comparison with Other Paclitaxel Systems in Vitro and in Vivo","volume":"471","author":"Lu","year":"2014","journal-title":"Int. J. Pharm."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226008334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T22:49:01Z","timestamp":1787179741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226008334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":85,"alternative-id":["S0753332226008334"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119797","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paclitaxel-loaded nanostructured lipid carriers surface-functionalized with N6L for pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119797"}}